tiprankstipranks
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
US Market

Ginkgo Bioworks Holdings (DNA) Financial Statements

Compare
2,173 Followers

Ginkgo Bioworks Holdings Financial Overview

Ginkgo Bioworks Holdings's market cap is currently $791.48M. The company's EPS TTM is $-12.903; its P/E ratio is ―; Ginkgo Bioworks Holdings is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-1.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 251.46M$ 477.71M$ 313.84M$ 76.66M$ 54.18M
Gross Profit$ 197.45M$ 273.49M$ 184.15M$ 61.05M$ 54.18M
Operating Income$ -864.41M$ -2.21B$ -1.83B$ -137.03M$ -71.60M
EBITDA$ -821.29M$ -2.06B$ -1.81B$ -108.58M$ -106.66M
Net Income$ -892.87M$ -2.10B$ -1.83B$ -126.61M$ -119.33M
Balance Sheet
Cash & Short-Term Investments$ 944.07M$ 1.32B$ 1.55B$ 380.80M$ 495.29M
Total Assets$ 1.67B$ 2.54B$ 2.07B$ 675.15M$ 697.32M
Total Debt$ 241.77M$ 442.59M$ 23.03M$ 17.00M$ 16.77M
Net Debt$ -702.30M$ -873.20M$ -1.53B$ -363.80M$ -478.52M
Total Liabilities$ 568.19M$ 803.04M$ 503.61M$ 205.10M$ 195.47M
Stockholders' Equity$ 1.10B$ 1.74B$ 1.51B$ 461.38M$ 493.06M
Cash Flow
Free Cash Flow$ -336.30M$ -304.47M$ -310.34M$ -193.65M$ -66.88M
Operating Cash Flow$ -295.50M$ -252.20M$ -253.82M$ -135.83M$ -44.66M
Investing Cash Flow$ -80.69M$ -67.39M$ -73.26M$ -67.12M$ -74.60M
Financing Cash Flow$ -3.22M$ 95.34M$ 1.53B$ 90.32M$ 410.38M
Currency in USD

Ginkgo Bioworks Holdings Earnings and Revenue History

Ginkgo Bioworks Holdings Debt to Assets

Ginkgo Bioworks Holdings Cash Flow

Ginkgo Bioworks Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis